Cargando…
Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model
BACKGROUND: Symptomatic treatments of Alzheimer’s Disease (AD) with cholinesterase inhibitors and/or memantine are relatively ineffective and there is a need for new treatments targeting the underlying pathology of AD. In most of the failed disease-modifying trials, patients have been allowed to con...
Autores principales: | Riedel, Gernot, Klein, Jochen, Niewiadomska, Grazyna, Kondak, Constantin, Schwab, Karima, Lauer, Dilyara, Magbagbeolu, Mandy, Steczkowska, Marta, Zadrozny, Maciej, Wydrych, Malgorzata, Cranston, Anna, Melis, Valeria, Santos, Renato X., Theuring, Franz, Harrington, Charles R., Wischik, Claude M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403648/ https://www.ncbi.nlm.nih.gov/pubmed/32091331 http://dx.doi.org/10.2174/1567205017666200224120926 |
Ejemplares similares
-
Differential compartmental processing and phosphorylation of pathogenic human tau and native mouse tau in the line 66 model of frontotemporal dementia
por: Lemke, Nora, et al.
Publicado: (2021) -
Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks
por: Schwab, Karima, et al.
Publicado: (2021) -
Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s disease and frontotemporal lobar degeneration
por: Cranston, Anna L, et al.
Publicado: (2020) -
Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice
por: Kondak, Constantin, et al.
Publicado: (2023) -
Tau Oligomers Neurotoxicity
por: Niewiadomska, Grazyna, et al.
Publicado: (2021)